1. What are the U.S. point of care (PoC) diagnostics market statistics?

The market size was valued at USD 9.69 billion in 2024 and is projected to grow to USD 18.83 billion by 2034.

2. What is the growth rate of the U.S. point of care (PoC) diagnostics market value?

The market is projected to register a CAGR of 6.88% during the forecast period.

3. Who are the key players in the market?

A few of the key players in the market are include Abbott; Agilent Technologies, Inc.; BD; BIOMÉRIEUX; Danaher Corporation; Hologic, Inc.; Illumina, Inc.; Quest Diagnostics Incorporated; QuidelOrtho Corporation; and Thermo Fisher Scientific Inc.

4. Which segment, by product, dominated the U.S. point of care (PoC) diagnostics Market revenue share in 2024?

The infectious diseases segment accounted for 36.91% revenue share in 2024.

5. Which segment, by mode of prescription, is expected to witness the fastest growth during the forecast period?

The OTC segment is expected to witness significant growth at a CAGR of 1.8% during the forecast period.

U.S. Point of Care (PoC) Diagnostics Market Growth Opportunities, Industry Revenue, 2025-2034

REPORT DETAILS

Report Code: PM6438

No. of Pages: 126

Format: PDF

Published Date: September 2025

Base Year: 2024

Historical Data: 2020-2023

BUY NOW

Table of Contents

1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. U.S. Point-of-Care (PoC) diagnostics Market Insights
4.1. U.S. Point-of-Care (PoC) diagnostics Market – Market Snapshot
4.2. U.S. Point-of-Care (PoC) diagnostics Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Growing Prevalence of Chronic Diseases
4.2.1.2. Rising Advancement in PoC Technology
4.2.2. Restraints and Challenges
4.2.2.1. High procedure costs
4.2.3. Public opinion and privacy legal precedents
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. U.S. Point-of-Care (PoC) diagnostics Market Trends
4.6. Value Chain Analysis
5. U.S. Point-of-Care (PoC) diagnostics Market, By Product
5.1. Key Findings
5.2. Introduction
5.2.1. U.S. Point-of-Care (PoC) diagnostics Market, By Product, by Region, 2020–2034 (USD Billion)
5.3. Glucose Testing
5.3.1. U.S. Point-of-Care (PoC) diagnostics Market, by Glucose Testing, by Region, 2020–2034 (USD Billion)
5.4. Hb1Ac Testing
5.4.1. U.S. Point-of-Care (PoC) diagnostics Market, by Hb1Ac Testing, by Region, 2020–2034 (USD Billion)
5.5. Coagulation
5.5.1. U.S. Point-of-Care (PoC) diagnostics Market, by Coagulation, by Region, 2020–2034 (USD Billion)
5.6. Fertility
5.6.1. U.S. Point-of-Care (PoC) diagnostics Market, by Fertility, by Region, 2020–2034 (USD Billion)
5.7. Infectious Diseases
5.7.1. U.S. Point-of-Care (PoC) diagnostics Market, by Infectious Diseases, by Region, 2020–2034 (USD Billion)
5.7.2. HIV
5.7.2.1. U.S. Point-of-Care (PoC) diagnostics Market, by HIV, by Region, 2020–2034 (USD Billion)
5.7.3. Clostridium Difficile
5.7.3.1. U.S. Point-of-Care (PoC) diagnostics Market, by Clostridium Difficile, by Region, 2020–2034 (USD Billion)
5.7.4. HBV
5.7.4.1. U.S. Point-of-Care (PoC) diagnostics Market, by HBV, by Region, 2020–2034 (USD Billion)
5.7.5. Pneumonia or Streptococcus Associated Infections
5.7.5.1. U.S. Point-of-Care (PoC) diagnostics Market, by Pneumonia or Streptococcus Associated Infections, by Region, 2020–2034 (USD Billion)
5.7.6. Respiratory Syncytial Virus (RSV)
5.7.6.1. U.S. Point-of-Care (PoC) diagnostics Market, by Respiratory Syncytial Virus (RSV), by Region, 2020–2034 (USD Billion)
5.7.7. HPV
5.7.7.1. U.S. Point-of-Care (PoC) diagnostics Market, by HPV, by Region, 2020–2034 (USD Billion)
5.7.8. Influenza/Flu
5.7.8.1. U.S. Point-of-Care (PoC) diagnostics Market, by Influenza/Flu, by Region, 2020–2034 (USD Billion)
5.7.9. HCV
5.7.9.1. U.S. Point-of-Care (PoC) diagnostics Market, by HCV, by Region, 2020–2034 (USD Billion)
5.7.10. MRSA
5.7.10.1. U.S. Point-of-Care (PoC) diagnostics Market, by MRSA, by Region, 2020–2034 (USD Billion)
5.7.11. TB and Drug-Resistant TB
5.7.11.1. U.S. Point-of-Care (PoC) diagnostics Market, by TB and Drug-Resistant TB, by Region, 2020–2034 (USD Billion)
5.7.12. HSV
5.7.12.1. U.S. Point-of-Care (PoC) diagnostics Market, by HSV, by Region, 2020–2034 (USD Billion)
5.7.13. Others
5.7.13.1. U.S. Point-of-Care (PoC) diagnostics Market, by Others, by Region, 2020–2034 (USD Billion)
5.8. Cardiac Markers
5.8.1. U.S. Point-of-Care (PoC) diagnostics Market, by Cardiac Markers, by Region, 2020–2034 (USD Billion)
5.9. Thyroid Stimulating Hormone
5.9.1. U.S. Point-of-Care (PoC) diagnostics Market, by Thyroid Stimulating Hormone, by Region, 2020–2034 (USD Billion)
5.10. Hematology
5.10.1. U.S. Point-of-Care (PoC) diagnostics Market, by Hematology, by Region, 2020–2034 (USD Billion)
5.11. Primary Care Systems
5.11.1. U.S. Point-of-Care (PoC) diagnostics Market, by Primary Care Systems, by Region, 2020–2034 (USD Billion)
5.12. Decentralized Clinical Chemistry
5.12.1. U.S. Point-of-Care (PoC) diagnostics Market, by Decentralized Clinical Chemistry, by Region, 2020–2034 (USD Billion)
5.13. Feces
5.13.1. U.S. Point-of-Care (PoC) diagnostics Market, by Feces, by Region, 2020–2034 (USD Billion)
5.14. Lipid Testing
5.14.1. U.S. Point-of-Care (PoC) diagnostics Market, by Lipid Testin, by Region, 2020–2034 (USD Billion)
5.15. Cancer Marker
5.15.1. U.S. Point-of-Care (PoC) diagnostics Market, by Cancer Marker, by Region, 2020–2034 (USD Billion)
5.16. Blood Gas/Electrolytes
5.16.1. U.S. Point-of-Care (PoC) diagnostics Market, by Blood Gas/Electrolytes, by Region, 2020–2034 (USD Billion)
5.17. Ambulatory Chemistry
5.17.1. U.S. Point-of-Care (PoC) diagnostics Market, by Ambulatory Chemistry, by Region, 2020–2034 (USD Billion)
5.18. Drug Abuse Testing
5.18.1. U.S. Point-of-Care (PoC) diagnostics Market, by Drug Abuse Testing, by Region, 2020–2034 (USD Billion)
5.19. Urinalysis
5.19.1. U.S. Point-of-Care (PoC) diagnostics Market, by Urinalysis, by Region, 2020–2034 (USD Billion)
6. U.S. Point-of-Care (PoC) diagnostics Market, By Mode of Prescription
6.1. Key Findings
6.2. Introduction
6.2.1. U.S. Point-of-Care (PoC) diagnostics Market, By Mode of Prescription, by Region, 2020–2034 (USD Billion)
6.3. OTC
6.3.1. U.S. Point-of-Care (PoC) diagnostics Market, by OTC, by Region, 2020–2034 (USD Billion)
6.4. Prescription-based
6.4.1. U.S. Point-of-Care (PoC) diagnostics Market, by Prescription-based, by Region, 2020–2034 (USD Billion)
7. U.S. Point-of-Care (PoC) diagnostics Market, By End Use
7.1. Key Findings
7.2. Introduction
7.2.1. U.S. Point-of-Care (PoC) diagnostics Market, By End Use, by Region, 2020–2034 (USD Billion)
7.3. Clinics
7.3.1. U.S. Point-of-Care (PoC) diagnostics Market, by Clinics, by Region, 2020–2034 (USD Billion)
7.3.2. Physician Office
7.3.2.1. U.S. Point-of-Care (PoC) diagnostics Market, by Physician Office, by Region, 2020–2034 (USD Billion)
7.3.3. Pharmacy & Retail Clinics
7.3.3.1. U.S. Point-of-Care (PoC) diagnostics Market, by Pharmacy & Retail Clinics, by Region, 2020–2034 (USD Billion)
7.3.4. Non-practice Clinics
7.3.4.1. U.S. Point-of-Care (PoC) diagnostics Market, by Non-practice Clinics, by Region, 2020–2034 (USD Billion)
7.3.5. Urgent Care Clinic
7.3.5.1. U.S. Point-of-Care (PoC) diagnostics Market, by Urgent Care Clinic, by Region, 2020–2034 (USD Billion)
7.4. Hospitals
7.4.1. U.S. Point-of-Care (PoC) diagnostics Market, by Hospitals, by Region, 2020–2034 (USD Billion)
7.5. Home
7.5.1. U.S. Point-of-Care (PoC) diagnostics Market, by Home, by Region, 2020–2034 (USD Billion)
7.6. Assisted Living Healthcare Facilities
7.6.1. U.S. Point-of-Care (PoC) diagnostics Market, by Assisted Living Healthcare Facilities, by Region, 2020–2034 (USD Billion)
7.7. Laboratory
7.7.1. U.S. Point-of-Care (PoC) diagnostics Market, by Laboratory, by Region, 2020–2034 (USD Billion)
8. Competitive Landscape
8.1. Expansion and Acquisition Analysis
8.1.1. Expansion
8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
9.1. Abbott
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Recent Development
9.2. Agilent Technologies, Inc.
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Benchmarking
9.2.4. Recent Development
9.3. BD
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Benchmarking
9.3.4. Recent Development
9.4. BIOMÉRIEUX
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Recent Development
9.5. Danaher Corporation
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Recent Development
9.6. Hologic, Inc.
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product Benchmarking
9.6.4. Recent Development
9.7. Illimina, Inc.
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product Benchmarking
9.7.4. Recent Development
9.8. Quest Diagnostics Incorporated
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. Product Benchmarking
9.8.4. Recent Development
9.9. QuidelOrtho Corporation
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Product Benchmarking
9.9.4. Recent Development
9.10. Thermo Fisher Scientific Inc
9.10.1. Company Overview
9.10.2. Financial Performance
9.10.3. Product Benchmarking
9.10.4. Recent Development

List of Tables:

Table 1 US: Point-of-Care (PoC) diagnostics Market, by Product, by Region, 2020-2034 (USD Billion)
Table 2 US: Point-of-Care (PoC) diagnostics Market, by Mode of Prescription, by Region, 2020-2034 (USD Billion)
Table 3 US: Point-of-Care (PoC) diagnostics Market, by End Use, by Region, 2020-2034 (USD Billion)

List of Figures:

Figure 1. U.S. Point-of-Care (PoC) diagnostics Market, by Region, 2020–2034 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Porter’s Five Forces
Figure 5. Market by Product
Figure 6. U.S. Point-of-Care (PoC) diagnostics Market, By Product, 2024 & 2034 (USD Billion)
Figure 7. Market by Mode of Prescription
Figure 8. U.S. Point-of-Care (PoC) diagnostics Market, By Mode of Prescription, 2024 & 2034 (USD Billion)
Figure 9. Market by End Use
Figure 10. U.S. Point-of-Care (PoC) diagnostics Market, By End Use, 2024 & 2034 (USD Billion)

U.S. Point of Care (PoC) Diagnostics Market Growth Opportunities, Industry Revenue, 2025-2034

Download Sample Report of U.S. Point of Care (PoC) Diagnostics Market